Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)
Trial details
- Registry ID
- NCT07029412
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)NCT07029412 | MBX Biosciences | Phase 2 | Completed | 2026-04-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |